Related references
Note: Only part of the references are listed.Cannabinoid Replacement Therapy (CRT): Nabiximols (Sativex) as a Novel Treatment for Cannabis Withdrawal
D. J. Allsop et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy
Craig A. Press et al.
EPILEPSY & BEHAVIOR (2015)
Attenuation of kainic acid-induced status epilepticus by inhibition of endocannabinoid transport and degradation in guinea pigs
Liubov Shubina et al.
EPILEPSY RESEARCH (2015)
Placebo effect of medication cost in Parkinson disease A randomized double-blind study
Alberto J. Espay et al.
NEUROLOGY (2015)
Effects of WIN 55,212-2 (a synthetic cannabinoid CB1 and CB2 receptor agonist) on the anticonvulsant activity of various novel antiepileptic drugs against 6 Hz-induced psychomotor seizures in mice
Magdalena Florek-Luszczki et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2015)
Involvement of PPAR receptors in the anticonvulsant effects of a cannabinoid agonist, WIN 55,212-2
Borna Payandemehr et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2015)
Fewer specialists support using medical marijuana and CBD in treating epilepsy patients compared with other medical professionals and patients: Result of Epilepsia's survey
Gary W. Mathern et al.
EPILEPSIA (2015)
Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling
Barna Dudok et al.
NATURE NEUROSCIENCE (2015)
Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications
Marisol S. Castaneto et al.
DRUG AND ALCOHOL DEPENDENCE (2014)
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review
Stephen M. Stout et al.
DRUG METABOLISM REVIEWS (2014)
Miswiring the brain: Δ9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway
Giuseppe Tortoriello et al.
EMBO JOURNAL (2014)
The case for medical marijuana in epilepsy
Edward Maa et al.
EPILEPSIA (2014)
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
Orrin Devinsky et al.
EPILEPSIA (2014)
Cannabis, cannabidiol, and epilepsy - From receptors to clinical response
Jerzy P. Szaflarski et al.
EPILEPSY & BEHAVIOR (2014)
Influence of WIN 55,212-2 on the anticonvulsant and acute neurotoxic potential of clobazam and lacosamide in the maximal electroshock-induced seizure model and chimney test in mice
Magdalena Florek-Luszczki et al.
EPILEPSY RESEARCH (2014)
Cannabis and other illicit drug use in epilepsy patients
M. Hamerle et al.
EUROPEAN JOURNAL OF NEUROLOGY (2014)
THC:CBD Spray and MS Spasticity Symptoms: Data from Latest Studies
Tiina Rekand
EUROPEAN NEUROLOGY (2014)
Effects of WIN 55,212-2 (a non-selective cannabinoid CB1 and CB2 receptor agonist) on the protective action of various classical antiepileptic drugs in the mouse 6 Hz psychomotor seizure model
Magdalena Florek-Luszczki et al.
JOURNAL OF NEURAL TRANSMISSION (2014)
Cannabis Use Is Quantitatively Associated with Nucleus Accumbens and Amygdala Abnormalities in Young Adult Recreational Users
Jodi M. Gilman et al.
JOURNAL OF NEUROSCIENCE (2014)
Presynaptic Calcium Channel Inhibition Underlies CB1 Cannabinoid Receptor-Mediated Suppression of GABA Release
G. Szabo Gergely et al.
JOURNAL OF NEUROSCIENCE (2014)
Cortical Thickness and Neurocognition in Adolescent Marijuana and Alcohol Users Following 28 Days of Monitored Abstinence
Joanna Jacobus et al.
JOURNAL OF STUDIES ON ALCOHOL AND DRUGS (2014)
The challenge and promise of anti-epileptic therapy development in animal models
Michele Simonato et al.
LANCET NEUROLOGY (2014)
Loss of cholecystokinin-containing terminals in temporal lobe epilepsy
Chengsan Sun et al.
NEUROBIOLOGY OF DISEASE (2014)
Effects of cannabis on cognition in patients with MS A psychometric and MRI study
Bennis Pavisian et al.
NEUROLOGY (2014)
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders Report of the Guideline Development Subcommittee of the American Academy of Neurology
Barbara S. Koppel et al.
NEUROLOGY (2014)
Permanent suppression of cortical oscillations in mice after adolescent exposure to cannabinoids: Receptor mechanisms
Sylvina M. Raver et al.
NEUROPHARMACOLOGY (2014)
Characterizing cannabis-induced psychosis: A study with prepulse inhibition of the startle reflex
Isabel Morales-Munoz et al.
PSYCHIATRY RESEARCH (2014)
Worth the wait: effects of age of onset of marijuana use on white matter and impulsivity
Staci A. Gruber et al.
PSYCHOPHARMACOLOGY (2014)
Seizing an Opportunity for the Endocannabinoid System
Bradley E. Alger
EPILEPSY CURRENTS (2014)
Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal A Randomized Clinical Trial
David J. Allsop et al.
JAMA PSYCHIATRY (2014)
Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings
Maren Hermanns-Clausen et al.
ADDICTION (2013)
Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism
T. D. M. Hill et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Cannabidiol Is a Potent Inhibitor of the Catalytic Activity of Cytochrome P450 2C19
Rongrong Jiang et al.
DRUG METABOLISM AND PHARMACOKINETICS (2013)
Acute intoxication by synthetic cannabinoids - Four case reports
Maren Hermanns-Clausen et al.
DRUG TESTING AND ANALYSIS (2013)
The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs
Michael A. Rogawski
EPILEPSIA (2013)
The role of potassium BK channels in anticonvulsant effect of cannabidiol in pentylenetetrazole and maximal electroshock models of seizure in mice
Zahra Shirazi-Zand et al.
EPILEPSY & BEHAVIOR (2013)
Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy
Brenda E. Porter et al.
EPILEPSY & BEHAVIOR (2013)
CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations
Rita Citraro et al.
EPILEPSY RESEARCH (2013)
Effects of cannabinoids and endocannabinoid hydrolysis inhibition on pentylenetetrazole-induced seizure and electroencephalographic activity in rats
Luciano R. Vilela et al.
EPILEPSY RESEARCH (2013)
First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201
David McQuade et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Effects of WIN 55,212-2 mesylate on the anticonvulsant action of lamotrigine, oxcarbazepine, pregabalin and topiramate against maximal electroshock-induced seizures in mice
Jarogniew J. Luszczki et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report
J. A. S. Crippa et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2013)
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
Amir Englund et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Preliminary Evidence for a Sex-Specific Relationship between Amount of Cannabis Use and Neurocognitive Performance in Young Adult Cannabis Users
Natania A. Crane et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2013)
Adolescent Cannabinoid Exposure Permanently Suppresses Cortical Oscillations in Adult Mice
Sylvina M. Raver et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Placebo effects in children: a review
Katja Weimer et al.
PEDIATRIC RESEARCH (2013)
Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses
Sergiy Sylantyev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Glia and epilepsy: excitability and inflammation
Orrin Devinsky et al.
TRENDS IN NEUROSCIENCES (2013)
Functional connectivity and cannabis use in high-risk adolescents
Jon M. Houck et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2013)
Dare to Delay? The Impacts of Adolescent Alcohol and Marijuana Use Onset on Cognition, Brain Structure, and Function
Krista M. Lisdahl et al.
Frontiers in Psychiatry (2013)
Spicy Seizure
Sadip Pant et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2012)
Cannabidivarin is anticonvulsant in mouse and rat
A. J. Hill et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Statistical parametric mapping reveals regional alterations in cannabinoid CB1 receptor distribution and G-protein activation in the 3D reconstructed epileptic rat brain
Katherine W. Sayers et al.
EPILEPSIA (2012)
Seizure exacerbation in two patients with focal epilepsy following marijuana cessation
Manu Hegde et al.
EPILEPSY & BEHAVIOR (2012)
Involvement of transient receptor potential vanilloid type 1 channels in the pro-convulsant effect of anandamide in pentylenetetrazole-induced seizures
Shyamshree S. S. Manna et al.
EPILEPSY RESEARCH (2012)
Internet Highs-Seizures After Consumption of Synthetic Cannabinoids Purchased Online
Babak Tofighi et al.
JOURNAL OF ADDICTION MEDICINE (2012)
Synthetic Cannabis and Respiratory Depression
Felecia N. Jinwala et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2012)
Equipotent Inhibition of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase - Dual Targets of the Endocannabinoid System to Protect against Seizure Pathology
Vinogran Naidoo et al.
NEUROTHERAPEUTICS (2012)
Phytocannabinoids as novel therapeutic agents in CNS disorders
Andrew J. Hill et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Inverse relationship of cannabimimetic (R+)WIN 55, 212 on behavior and seizure threshold during the juvenile period
V. Rudenko et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
Effect of ACEA-a selective cannabinoid CB1 receptor agonist on the protective action of different antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model
Marta Andres-Mach et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures
Nicholas A. Jones et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2012)
Inflammation and Epilepsy: The Foundations for a New Therapeutic Approach in Epilepsy?
Lauren Walker et al.
EPILEPSY CURRENTS (2012)
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
Luciano De Petrocellis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
Ethan B. Russo
BRITISH JOURNAL OF PHARMACOLOGY (2011)
The Non-Psychoactive Plant Cannabinoid, Cannabidiol Affects Cholesterol Metabolism-Related Genes in Microglial Cells
Neta Rimmerman et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2011)
Severe Toxicity Following Synthetic Cannabinoid Ingestion
J. Lapoint et al.
CLINICAL TOXICOLOGY (2011)
Cannabidiol, a Major Phytocannabinoid, As a Potent Atypical Inhibitor for CYP2D6
Satoshi Yamaori et al.
DRUG METABOLISM AND DISPOSITION (2011)
Targeting the endocannabinoid system in the amygdala kindling model of temporal lobe epilepsy in mice
Hannes Wendt et al.
EPILEPSIA (2011)
The effect of co-administration of the NMDA blocker with agonist and antagonist of CB1-receptor on penicillin-induced epileptiform activity in rats
Duygu Cakil et al.
EPILEPSY RESEARCH (2011)
Pro-epileptic effects of the cannabinoid receptor antagonist SR141716 in a model of audiogenic epilepsy
Lyudmila V. Vinogradova et al.
EPILEPSY RESEARCH (2011)
Cannabinoids inhibit the synaptic uptake of adenosine and dopamine in the rat and mouse striatum
Pablo Pandolfo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Prolonged cannabinoid exposure alters GABAA receptor mediated synaptic function in cultured hippocampal neurons
Laxmikant S. Deshpande et al.
EXPERIMENTAL NEUROLOGY (2011)
Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine
Philip Robson
EXPERT OPINION ON DRUG SAFETY (2011)
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
George W. Booz
FREE RADICAL BIOLOGY AND MEDICINE (2011)
An Evidence-Based Review of Acute and Long-Term Effects of Cannabis Use on Executive Cognitive Functions
Rebecca D. Crean et al.
JOURNAL OF ADDICTION MEDICINE (2011)
Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes
Rongrong Jiang et al.
LIFE SCIENCES (2011)
Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: Role of phenolic hydroxyl groups in the resorcinol moiety
Satoshi Yamaori et al.
LIFE SCIENCES (2011)
The role of inflammation in epilepsy
Annamaria Vezzani et al.
NATURE REVIEWS NEUROLOGY (2011)
Modulation of Anticonvulsant Effects of Cannabinoid Compounds by GABA-A Receptor Agonist in Acute Pentylenetetrazole Model of Seizure in Rat
Nima Naderi et al.
NEUROCHEMICAL RESEARCH (2011)
CURRENT CONCEPTS Drug-Resistant Epilepsy
Patrick Kwan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Redistribution of CB1 Cannabinoid Receptors in the Acute and Chronic Phases of Pilocarpine-Induced Epilepsy
Maria R. Karlocai et al.
PLOS ONE (2011)
Synthetic cannabinoid WIN 55,212-2 mesylate enhances the protective action of four classical antiepileptic drugs against maximal electroshock-induced seizures in mice
Jarogniew J. Luszczki et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2011)
Effects of WIN 55,212-2 mesylate (a synthetic cannabinoid) on the protective action of clonazepam, ethosuximide, phenobarbital and valproate against pentylenetetrazole-induced clonic seizures in mice
Jarogniew J. Luszczki et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Cannabis with high cannabidiol content is associated with fewer psychotic experiences
Christian D. Schubart et al.
SCHIZOPHRENIA RESEARCH (2011)
Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs
Wolfgang Loescher
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2011)
Treatment of Lennox-Gastaut syndrome: overview and recent findings
Kenou Rijckevorsel
Neuropsychiatric Disease and Treatment (2011)
The Secret Spice'': An Undetectable Toxic Cause of Seizure
Adam de Havenon et al.
NEUROHOSPITALIST (2011)
Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes
Satoshi Yamaori et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Adenosine-cannabinoid receptor interactions. Implications for striatal function
Sergi Ferre et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy
Andrea Romigi et al.
EPILEPSIA (2010)
The effect of the cannabinoid-receptor antagonist, SR141716, on the early stage of kainate-induced epileptogenesis in the adult rat
F. Edward Dudek et al.
EPILEPSIA (2010)
Dynamic changes of CB1-receptor expression in hippocampi of epileptic mice and humans
Zsofia Magloczky et al.
EPILEPSIA (2010)
WAG/Rij rats show a reduced expression of CB1 receptors in thalamic nuclei and respond to the CB1 receptor agonist, R(+)WIN55,212-2, with a reduced incidence of spike-wave discharges
Clementina M. van Rijn et al.
EPILEPSIA (2010)
Non-CB1, Non-CB2 Receptors for Endocannabinoids, Plant Cannabinoids, and Synthetic Cannabimimetics: Focus on G-protein-coupled Receptors and Transient Receptor Potential Channels
Luciano De Petrocellis et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2010)
Selective Reduction of Cholecystokinin-Positive Basket Cell Innervation in a Model of Temporal Lobe Epilepsy
Megan S. Wyeth et al.
JOURNAL OF NEUROSCIENCE (2010)
Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo
Nicholas A. Jones et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Cannabinoid-Mediated Inhibition of Recurrent Excitatory Circuitry in the Dentate Gyrus in a Mouse Model of Temporal Lobe Epilepsy
Muthu D. Bhaskaran et al.
PLOS ONE (2010)
AAV Vector-Mediated Overexpression of CB1 Cannabinoid Receptor in Pyramidal Neurons of the Hippocampus Protects against Seizure-Induced Excitoxicity
Stephan Guggenhuber et al.
PLOS ONE (2010)
Effect of arachidonyl-2′-chloroethylamide, a selective cannabinoid CB1 receptor agonist, on the protective action of the various antiepileptic drugs in the mouse maximal electroshock-induced seizure model
Jarogniew J. Luszczki et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
Therapeutic Time Window of Cannabidiol Treatment on Delayed Ischemic Damage via High-Mobility Group Box1-Inhibiting Mechanism
Kazuhide Hayakawa et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2009)
Temporal characterization of changes in hippocampal cannabinoid CB1 receptor expression following pilocarpine-induced status epilepticus
Katherine W. Falenski et al.
BRAIN RESEARCH (2009)
The effects of intracerebroventricular AM-251, a CB1-receptor antagonist, and ACEA, a CB1-receptor agonist, on penicillin-induced epileptiform activity in rats
Ramazan Kozan et al.
EPILEPSIA (2009)
Involvement of nitrergic system in the anticonvulsant effect of the cannabinoid CB1 agonist ACEA in the pentylenetetrazole-induced seizure in mice
Arash Bahremand et al.
EPILEPSY RESEARCH (2009)
Single application of a CB1 receptor antagonist rapidly following head injury prevents long-term hyperexcitability in a rat model
Julio Echegoyen et al.
EPILEPSY RESEARCH (2009)
Differential changes in GPR55 during microglial cell activation
Maciej Pietr et al.
FEBS LETTERS (2009)
Cannabidiol Targets Mitochondria to Regulate Intracellular Ca2+ Levels
Duncan Ryan et al.
JOURNAL OF NEUROSCIENCE (2009)
Prolonged exposure to WIN55,212-2 causes downregulation of the CB1 receptor and the development of tolerance to its anticonvulsant effects in the hippocampal neuronal culture model of acquired epilepsy
Robert E. Blair et al.
NEUROPHARMACOLOGY (2009)
Evidences of cannabinoids-induced modulation of paroxysmal events in an experimental model of partial epilepsy in the rat
Valerio Rizzo et al.
NEUROSCIENCE LETTERS (2009)
Synergy research: Approaching a new generation of phytopharmaceuticals
H. Wagner et al.
PHYTOMEDICINE (2009)
The Nonpsychotropic Cannabinoid Cannabidiol Modulates and Directly Activates Alpha-1 and Alpha-1-Beta Glycine Receptor Function
Joerg Ahrens et al.
PHARMACOLOGY (2009)
The enigmatic pharmacology of GPR55
Ruth A. Ross
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Cannabinoid CB2 receptors in human brain inflammation
C. Benito et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Quality-of-life trajectories in epilepsy: A review of the literature
Ann Jacoby et al.
EPILEPSY & BEHAVIOR (2008)
The cannabinoid anticonvulsant effect on pentylenetetrazole-induced seizure is potentiated by ultra-low dose naltrexone in mice
Arash Bahremand et al.
EPILEPSY RESEARCH (2008)
Inhibition of recombinant human T-type calcium channels by Δ9-Tetrahydrocannabinol and cannabidiol
Hamish Redmond Ross et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Phytochemical and genetic analyses of ancient cannabis from Central Asia
Ethan B. Russo et al.
JOURNAL OF EXPERIMENTAL BOTANY (2008)
Evaluation of interactions between cannabinoid compounds and diazepam in electroshock-induced seizure model in mice
Nima Naderi et al.
JOURNAL OF NEURAL TRANSMISSION (2008)
Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus
Aniko Ludanyi et al.
JOURNAL OF NEUROSCIENCE (2008)
TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons
Ning Qin et al.
JOURNAL OF NEUROSCIENCE (2008)
Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8
Luciano De Petrocellis et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Endocannabinoid signaling as a synaptic circuit breaker in neurological disease
Istvan Katona et al.
NATURE MEDICINE (2008)
Synergism between natural products and antibiotics against infectious diseases
Shanmugam Hemaiswarya et al.
PHYTOMEDICINE (2008)
The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain
Penny C. Staton et al.
PAIN (2008)
GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
Jane E. Lauckner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Greater response to placebo in children than in adults: A systematic review and meta-analysis in drug-resistant partial epilepsy
Sylvain Rheims et al.
PLOS MEDICINE (2008)
Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to Δ9-tetrahydrocannabinol
Diana L. McKinney et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Mediation of Cannabidiol Anti-inflammation in the Retina by Equilibrative Nucleoside Transporter and A2A Adenosine Receptor
Gregory I. Liou et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
GPR55: a new member of the cannabinoid receptor clan?
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The orphan receptor GPR55 is a novel cannabinoid receptor
E. Ryberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS expression
G. Esposito et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Δ9-Tetrahydrocannabinol (THC) and AM 404 protect against cerebral ischaemia in gerbils through a mechanism involving cannabinoid and opioid receptors
A. Zani et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Identification of GPR55 as a lysophosphatidylinositol receptor
Saori Oka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Ultra-low dose cannabinoid antagonist AM251 enhances cannabinoid anticonvulsant effects in the pentylenetetrazole-induced seizure in mice
Shervin Gholizadeh et al.
NEUROPHARMACOLOGY (2007)
Oromucosal Δ9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis:: An uncontrolled, open-label, 2-year extension trial
David J. Rog et al.
CLINICAL THERAPEUTICS (2007)
Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor-independent myeloperoxidase-inhibiting mechanism
Kazuhide Hayakawa et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Endocannabinoid enhancement protects against kainic acid-induced seizures and associated brain damage
David A. Karanian et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Molecular Components and Functions of the Endocannabinoid System in Mouse Prefrontal Cortex
Mathieu Lafourcade et al.
PLOS ONE (2007)
Distribution of type 1 cannabinoid receptor (CB1)-immunoreactive axons in the mouse hypothalamus
Gabor Wittmann et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2007)
Placebo response in asthma: A robust and objective phenomenon
Margaret E. Kemeny et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy
K. W. Falenski et al.
NEUROSCIENCE (2007)
Endocannabinoids block, status epilepticus in cultured hippocampal neurons
Laxmikant S. Deshpande et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Chronic use of marijuana decreases cannabinoid receptor binding and mRNA expression in the human brain
J. Villares
NEUROSCIENCE (2007)
Δ9-Tetrahydrocannabinol protects hippocampal neurons from excitotoxicity
Glenna L. Gilbert et al.
BRAIN RESEARCH (2007)
Prevention of plasticity of endocannabinoid signaling inhibits persistent limbic hyperexcitability caused by developmental seizures
Kang Chen et al.
JOURNAL OF NEUROSCIENCE (2007)
Cannabinoid type I receptor antagonists (rimonabant) for smoking cessation
K. Cahill et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2007)
Cannabis, pain, and sleep: Lessons from therapeutic clinical trials of Sativex((R)), a cannabis-based medicine
Ethan B. Russo et al.
CHEMISTRY & BIODIVERSITY (2007)
Arachidonyl-2'-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model
Jarogniew J. Luszczki et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Prolonged recovery rate of CB1 receptor adaptation after cessation of long-term cannabinoid administration
Laura J. Sim-Selley et al.
MOLECULAR PHARMACOLOGY (2006)
The endocannabinoid system controls key epileptogenic circuits in the hippocampus
Krisztina Monory et al.
NEURON (2006)
Combined cannabinoid therapy via an oromucosal spray
Jordi Perez
DRUGS OF TODAY (2006)
Molecular composition of the endocannabinoid system at glutamatergic synapses
István Katona et al.
JOURNAL OF NEUROSCIENCE (2006)
Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression
Erica J. Carrier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in β-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-κB involvement
Giuseppe Esposito et al.
NEUROSCIENCE LETTERS (2006)
The cannabis withdrawal syndrome
AJ Budney et al.
CURRENT OPINION IN PSYCHIATRY (2006)
Cannabidiol-induced intracellular Ca2+ elevations in hippocampal cells
AJ Drysdale et al.
NEUROPHARMACOLOGY (2006)
The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum
Y Kawamura et al.
JOURNAL OF NEUROSCIENCE (2006)
G protein βγ-subunits activated by serotonin mediate presynaptic inhibition by regulating vesicle fusion properties
H Photowala et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients - RIO-North America: A randomized controlled trial
F Pi-Sunyer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
The emerging role of the endocannabinoid system in endocrine regulation and energy balance
U Pagotto et al.
ENDOCRINE REVIEWS (2006)
A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol
E Russo et al.
MEDICAL HYPOTHESES (2006)
Chemical constituents of marijuana: The complex mixture of natural cannabinoids
MA ElSohly et al.
LIFE SCIENCES (2005)
Δ9-Tetrahydrocannabinol-induced desensitization of cannabinoid-mediated inhibition of synaptic transmission between hippocampal neurons in culture
DJ Lundberg et al.
NEUROPHARMACOLOGY (2005)
Dual modulation of endocannabinoid transport and fatty acid amide hydrolase protects against excitotoxicity
DA Karanian et al.
JOURNAL OF NEUROSCIENCE (2005)
Agonistic properties of cannabidiol at 5-HT1a receptors
EB Russo et al.
NEUROCHEMICAL RESEARCH (2005)
Epileptic seizures and epilepsy: Definitions proposed by the International League against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)
RS Fisher et al.
EPILEPSIA (2005)
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
Jared Ehrhart et al.
JOURNAL OF NEUROINFLAMMATION (2005)
Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on β-amyloid-induced toxicity in PC12 cells
T Iuvone et al.
JOURNAL OF NEUROCHEMISTRY (2004)
The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice
H Shafaroodi et al.
NEUROPHARMACOLOGY (2004)
Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons
M Melis et al.
JOURNAL OF NEUROSCIENCE (2004)
Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients
DT Wade et al.
MULTIPLE SCLEROSIS (2004)
Marijuana use and epilepsy - Prevalence in patients of a tertiary care epilepsy center
DW Gross et al.
NEUROLOGY (2004)
Signaling pathways involved in the development of cannabinoid tolerance
BR Martin et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Selective antiepileptic effects of N-palmitoylethanolamide, a putative endocannabinoid
AH Sheerin et al.
EPILEPSIA (2004)
Neuroprotective effect of(-)Δ9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity -: Involvement of peroxynitrite
AB El-Remessy et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
CB1 cannabinoid receptors and on-demand defense against excitotoxicity
G Marsicano et al.
SCIENCE (2003)
Brief presynaptic bursts evoke synapse-specific retrograde inhibition mediated by endogenous cannabinoids
SP Brown et al.
NATURE NEUROSCIENCE (2003)
The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy
MJ Wallace et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Long-term plasticity of endocannabinoid signaling induced by developmental febrile seizures
K Chen et al.
NEURON (2003)
Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs
PN Patsalos et al.
LANCET NEUROLOGY (2003)
The effects of Δ9-tetrahydrocannabinol physical dependence on brain cannabinoid receptors
CS Breivogel et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
The molecular logic of endocannabinoid signalling
D Piomelli
NATURE REVIEWS NEUROSCIENCE (2003)
Comparison of smoked marijuana and oral Δ9-tetrahydrocannabinol in humans
CL Hart et al.
PSYCHOPHARMACOLOGY (2002)
Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity
MJ Wallace et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Effect of chronic administration of R-(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (IN55,212-2) or Δ9-tetrahydrocannabinol on cannabinoid receptor adaptation in mice
LJ Sim-Selley et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures
F Molina-Holgado et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance
T Sugiura et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2002)
Cannabinoids and brain injury: therapeutic implications
R Mechoulam et al.
TRENDS IN MOLECULAR MEDICINE (2002)
SR 141716A prevents Δ9-tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice
GE Da Silva et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2002)
Refractory epilepsy: a progressive, intractable but preventable condition?
P Kwan et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2002)
Modulation of transmitter release via presynaptic cannabinoid receptors
E Schlicker et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2001)
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
T Bisogno et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Alcohol and marijuana: Effects on epilepsy and use by patients with epilepsy
E Gordon et al.
EPILEPSIA (2001)
Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects
MJ Wallace et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity
ME Abood et al.
NEUROSCIENCE LETTERS (2001)
Presynaptic specificity of endocannabinoid signaling in the hippocampus
RI Wilson et al.
NEURON (2001)
Endogenous cannabinoid as a retrograde messenger from depolarized postsynaptic neurons to presynaptic terminals
T Maejima et al.
NEUROSCIENCE RESEARCH (2001)
Blockade of effects of smoked marijuana by the CBl-selective cannabinoid receptor antagonist SR141716
MA Huestis et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice
DM Lambert et al.
EPILEPSIA (2001)
Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells
AC Kreitzer et al.
NEURON (2001)
Incidence and risk factors in sudden unexpected death in epilepsy - A prospective cohort study
TS Walczak et al.
NEUROLOGY (2001)
The effects of adolescent cannabis use on educational attainment: a review
M Lynskey et al.
ADDICTION (2000)
The cannabinoid system and cytokine network
TW Klein et al.
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE (2000)
Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development
RG Pertwee
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2000)
Early identification of refractory epilepsy.
P Kwan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Protein kinase-dependent phosphorylation and cannabinoid receptor modulation of potassium A current (I-A) in cultured rat hippocampal neurons
J Mu et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2000)
Is there a role for therapeutic drug monitoring of new anticonvulsants?
E Perucca
CLINICAL PHARMACOKINETICS (2000)
Share Paper
